Global Psoriasis Market and Competitive Landscape – 2017

Best Price Guarantee	Publisher	Published Date	SKU
from $3,990	Fore Pharma	August, 2017	FPCI15450477

Best Price Guarantee
Price	from $3,990
Publisher	Fore Pharma
Published Date	August, 2017
SKU	FPCI15450477

Global Psoriasis Market and Competitive Landscape – 2017

The latest research from Fore Pharma, Global Psoriasis Market and Competitive Landscape – 2017, provides comprehensive insights into Psoriasis pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Psoriasis market size and drug sales. This research also provides insights into Psoriasis epidemiology and late stage pipeline.
The report is classified into twelve sections – Psoriasis overview with definitions, symptoms, etiology, diagnosis, treatment options; Psoriasis pipeline insights covering late stage clinical trials pipeline; Psoriasis prevalence trends by countries; Psoriasis market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes G7 countries – US, Germany, France, Italy, Spain, UK, Japan, Europe, Global.

Research Scope:

Psoriasis pipeline: Find out the drugs in clinical trials for Psoriasis by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
Psoriasis epidemiology: Find out the prevalence of Psoriasis by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
Psoriasis products: Identify key products marketed and prescribed for Psoriasis by brand name, by molecule, by company, by branded / generic, by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
Psoriasis market size: Find out the market size for Psoriasis drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
Psoriasis drug sales: Find out the sales of Psoriasis drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
Psoriasis drugs sales forecast: Sales forecast for Psoriasis drugs to 2021 by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
Psoriasis market share analysis: Find out the market shares of Psoriasis drugs and outlook by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan

Benefits of this Research: The research helps executives to

Evaluate commercial market opportunities for Psoriasis drugs
Synthesize insights for business development & licensing
Track market size, competitor drug sales, market shares in Psoriasis market
Develop in-depth knowledge of competition and markets
Analyze sales data to update your brand planning trackers
Develop tactics and strategies to take advantage of opportunities in the market
Track market trends and analyze key events in Psoriasis market
Develop forecast models, healthcare frameworks, or economic models
Answer key business questions; supports decision making in R&D to long term marketing strategies

1. Psoriasis: Disease Overview: 1.1. Psoriasis Symptoms; 1.2. Psoriasis Etiology; 1.3. Psoriasis Diagnosis; 1.4. Psoriasis Treatment Options
2. Psoriasis Pipeline Insights: 2.1. Psoriasis Phase 3 Clinical Trials; 2.2. Psoriasis Phase 2 Clinical Trials; 2.3. Psoriasis Phase 1 Clinical Trials
3. Psoriasis Epidemiology Analysis
4. US Psoriasis Market Insights: 4.1. Marketed Products for Psoriasis in US; 4.2. US Psoriasis Market Size & Forecast; 4.3. US Psoriasis Product Sales Forecast; 4.4. US Psoriasis Market Share Analysis
5. Germany Psoriasis Market Insights: 5.1. Marketed Products for Psoriasis in Germany; 5.2. Germany Psoriasis Market Size & Forecast; 5.3. Germany Psoriasis Product Sales Forecast; 5.4. Germany Psoriasis Market Share Analysis
6. France Psoriasis Market Insights: 6.1. Marketed Products for Psoriasis in France; 6.2. France Psoriasis Market Size & Forecast; 6.3. France Psoriasis Product Sales Forecast; 6.4. France Psoriasis Market Share Analysis
7. Italy Psoriasis Market Insights: 7.1. Marketed Products for Psoriasis in Italy; 7.2. Italy Psoriasis Market Size & Forecast; 7.3. Italy Psoriasis Product Sales Forecast; 7.4. Italy Psoriasis Market Share Analysis
8. Spain Psoriasis Market Insights: 8.1. Marketed Products for Psoriasis in Spain; 8.2. Spain Psoriasis Market Size & Forecast; 8.3. Spain Psoriasis Product Sales Forecast; 8.4. Spain Psoriasis Market Share Analysis
9. UK Psoriasis Market Insights: 9.1. Marketed Products for Psoriasis in UK; 9.2. UK Psoriasis Market Size & Forecast; 9.3. UK Psoriasis Product Sales Forecast; 9.4. UK Psoriasis Market Share Analysis
10. Europe Psoriasis Market Insights: 10.1. Europe Psoriasis Market Size & Forecast; 10.2. Europe Psoriasis Product Sales Forecast; 10.3. Europe Psoriasis Market Share Analysis
11. Japan Psoriasis Market Insights: 11.1. Marketed Products for Psoriasis in Japan; 11.2. Japan Psoriasis Market Size & Forecast; 11.3. Japan Psoriasis Product Sales Forecast; 11.4. Japan Psoriasis Market Share Analysis
12. Global Psoriasis Market Insights: 12.1. Global Psoriasis Market Size & Forecast; 12.2. Global Psoriasis Product Sales Forecast; 12.3. Global Psoriasis Market Share Analysis
13. Research Methodology
LIST OF TABLES: Table 1: Psoriasis Phase 3 Clinical Trials, Global, 2017; Table 2: Psoriasis Phase 2 Clinical Trials, Global, 2017; Table 3: Psoriasis Phase 1 Clinical Trials, Global, 2017; Table 4: Psoriasis Prevalence by G7 Countries, 2012 - 2021; Table 5: Marketed Products for Psoriasis in US, 2017; Table 6: US Psoriasis Market Size & Forecast ($mn), 2012 - 2021; Table 7: US Psoriasis Product Sales ($mn), 2012 - 2021; Table 8: US Psoriasis Market Trends, 2012 - 2021; Table 9: Marketed Products for Psoriasis in Germany, 2017; Table 10: Germany Psoriasis Market Size & Forecast ($mn), 2012 - 2021; Table 11: Germany Psoriasis Product Sales ($mn), 2012 - 2021; Table 12: Germany Psoriasis Market Trends, 2012 - 2021; Table 13: Marketed Products for Psoriasis in France, 2017; Table 14: France Psoriasis Market Size & Forecast ($mn), 2012 - 2021; Table 15: France Psoriasis Product Sales ($mn), 2012 - 2021; Table 16: France Psoriasis Market Trends, 2012 - 2021; Table 17: Marketed Products for Psoriasis in Italy, 2017; Table 18: Italy Psoriasis Market Size & Forecast ($mn), 2012 - 2021; Table 19: Italy Psoriasis Product Sales ($mn), 2012 - 2021; Table 20: Italy Psoriasis Market Trends, 2012 - 2021; Table 21: Marketed Products for Psoriasis in Spain, 2017; Table 22: Spain Psoriasis Market Size & Forecast ($mn), 2012 - 2021; Table 23: Spain Psoriasis Product Sales ($mn), 2012 - 2021; Table 24: Spain Psoriasis Market Trends, 2012 - 2021; Table 25: Marketed Products for Psoriasis in UK, 2017; Table 26: UK Psoriasis Market Size & Forecast ($mn), 2012 - 2021; Table 27: UK Psoriasis Product Sales ($mn), 2012 - 2021; Table 28: UK Psoriasis Market Trends, 2012 - 2021; Table 29: Europe Psoriasis Market Size & Forecast ($mn), 2012 - 2021; Table 30: Europe Psoriasis Product Sales ($mn), 2012 - 2021; Table 31: Marketed Products for Psoriasis in Japan, 2017; Table 32: Japan Psoriasis Market Size & Forecast ($mn), 2012 - 2021; Table 33: Japan Psoriasis Product Sales ($mn), 2012 - 2021; Table 34: Japan Psoriasis Market Trends, 2012 - 2021; Table 35: Global Psoriasis Market Size & Forecast ($mn), 2012 - 2021; Table 36: Global Psoriasis Product Sales ($mn), 2012 - 2021
LIST OF FIGURES: Figure 1: Psoriasis Pipeline by Phase (%), Global, 2017; Figure 2: Psoriasis Prevalence by G7 Countries, 2012 - 2021; Figure 3: US Psoriasis Market Size ($mn), 2012 - 2021; Figure 4: US Psoriasis Product Sales ($mn), 2012 - 2021; Figure 5: US Psoriasis Market Share by Products (%), 2016; Figure 6: US Psoriasis Market - Future Market Share (%), 2021; Figure 7: Germany Psoriasis Market Size ($mn), 2012 - 2021; Figure 8: Germany Psoriasis Product Sales ($mn), 2012 - 2021; Figure 9: Germany Psoriasis Market Share by Products (%), 2016; Figure 10: Germany Psoriasis Market - Future Market Share (%), 2021; Figure 11: France Psoriasis Market Size ($mn), 2012 - 2021; Figure 12: France Psoriasis Product Sales ($mn), 2012 - 2021; Figure 13: France Psoriasis Market Share by Products (%), 2016; Figure 14: France Psoriasis Market - Future Market Share (%), 2021; Figure 15: Italy Psoriasis Market Size ($mn), 2012 - 2021; Figure 16: Italy Psoriasis Product Sales ($mn), 2012 - 2021; Figure 17: Italy Psoriasis Market Share by Products (%), 2016; Figure 18: Italy Psoriasis Market - Future Market Share (%), 2021; Figure 19: Spain Psoriasis Market Size ($mn), 2012 - 2021; Figure 20: Spain Psoriasis Product Sales ($mn), 2012 - 2021; Figure 21: Spain Psoriasis Market Share by Products (%), 2016; Figure 22: Spain Psoriasis Market - Future Market Share (%), 2021; Figure 23: UK Psoriasis Market Size ($mn), 2012 - 2021; Figure 24: UK Psoriasis Product Sales ($mn), 2012 - 2021; Figure 25: UK Psoriasis Market Share by Products (%), 2016; Figure 26: UK Psoriasis Market - Future Market Share (%), 2021; Figure 27: Europe Psoriasis Market Size ($mn), 2012 - 2021; Figure 28: Europe Psoriasis Product Sales ($mn), 2012 - 2021; Figure 29: Europe Psoriasis Market Share by Products (%), 2016; Figure 30: Europe Psoriasis Market - Future Market Share (%), 2021; Figure 31: Japan Psoriasis Market Size ($mn), 2012 - 2021; Figure 32: Japan Psoriasis Product Sales ($mn), 2012 - 2021; Figure 33: Japan Psoriasis Market Share by Products (%), 2016; Figure 34: Japan Psoriasis Market - Future Market Share (%), 2021; Figure 35: Global Psoriasis Market Size ($mn), 2012 - 2021; Figure 36: Global Psoriasis Product Sales ($mn), 2012 - 2021; Figure 37: Global Psoriasis Market Share by Products (%), 2016; Figure 38: Global Psoriasis Market - Future Market Share (%), 2021